The Roles of Noncoding RNAs in the Development of Osteosarcoma Stem Cells and Potential Therapeutic Targets

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Osteosarcoma (OS) is a prevalent bone tumor in children and adolescents with a poor prognosis due to chemotherapy resistance.
• Cancer stem cells (CSCs) contribute significantly to OS chemoresistance, tumor initiation, metastasis, recurrence, and poor outcomes.
• Noncoding RNAs (ncRNAs) have emerged as key regulators of CSC development and function.

Purpose of the Study:

• To review the critical roles of ncRNAs, including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs), in regulating CSCs in OS.
• To elucidate the potential mechanisms by which ncRNAs influence CSCs in the context of osteosarcoma.
• To highlight specific ncRNAs involved in OS CSC regulation for potential therapeutic targeting.

Main Methods:

• Literature review of studies investigating ncRNAs and their impact on CSCs in osteosarcoma.
• Analysis of reported mechanisms of ncRNA action on CSC self-renewal, multipotency, and drug resistance.
• Compilation of specific examples of miRNAs and lncRNAs implicated in OS CSC regulation.

Main Results:

• Numerous miRNAs (e.g., miR-26a, miR-29b, miR-34a) have been identified as regulators of OS CSCs.
• Several lncRNAs (e.g., B4GALT1-AS1, DANCR, MALAT1) play significant roles in controlling OS CSCs.
• ncRNAs are involved in key CSC processes including self-renewal, differentiation, and chemoresistance.

Conclusions:

• ncRNAs are crucial regulators of cancer stem cells in osteosarcoma.
• Targeting specific ncRNAs presents a novel and promising therapeutic strategy for eradicating OS CSCs.
• Further research into ncRNA-mediated regulation of OS CSCs could lead to improved treatment modalities for osteosarcoma patients.